Recently tested strategies to reduce nosocomial infections in the neonatal intensive care unit

Expert Review of Anti-Infective Therapy

Volumn 8, Issue 2, 2010, Pages 235-242

  Toltzis, Philip ^a   Walsh, Michele ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

care bundles; fluconazole; hand hygiene; newborn; nosocomial infection

Indexed keywords

FLUCONAZOLE; VANCOMYCIN; ANTIINFECTIVE AGENT;

BLOODSTREAM INFECTION; CATHETER INFECTION; CONTROL STRATEGY; DRUG EFFICACY; HAND WASHING; HEALTH CARE COST; HIGH RISK PATIENT; HOSPITAL INFECTION; HOSPITAL MANAGEMENT; HUMAN; INFANT MORTALITY; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; MYCOSIS; NEWBORN INTENSIVE CARE; NONHUMAN; REVIEW; CROSS INFECTION; HYGIENE; METHODOLOGY; NEWBORN;

ANTI-INFECTIVE AGENTS; COMMUNICABLE DISEASE CONTROL; CROSS INFECTION; FLUCONAZOLE; HANDWASHING; HUMANS; HYGIENE; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL;

EID: 77954514651     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.09.129     Document Type: Review

References (68)

1. Efird MM, Rojas MA, Lozano JM et al. Epidemiology of nosocomial infections in selected neonatal intensive care units in Colombia, South America. J. Perinatol. 25(8), 531-536 (2005).
2. Nagata E, Brito AS, Matsuo T. Nosocomial infections in a neonatal intensive care unit: Incidence and risk factors. Am. J. Infect. Control 30(1), 26-31 (2002).
3. Pessoa-Silva CL, Richtmann R, Calil R et al. Healthcare-associated infections among neonates in Brazil. Infect. Control Hosp. Epidemiol. 25(9), 772-777 (2004).
4. Jeong IS, Jeong JS, Choi EO. Nosocomial infection in a newborn intensive care unit (NICU), South Korea. BMC Infect. Dis. 6, 103 (2006).
5. Couto RC, Pedrosa TM, Tofani Cde P, Pedroso ER. Risk factors for nosocomial infection in a neonatal intensive care unit. Infect. Control Hosp. Epidemiol. 27(6), 571-575 (2006).
6. Schulman J, Stricof RL, Stevens TP et al. Development of a statewide collaborative to decrease NICU central line-associated bloodstream infections. J. Perinatol. 29(9), 591-599 (2009).
7. Aziz K, McMillan DD, Andrews W et al. Variations in rates of nosocomial infection among Canadian neonatal intensive care units may be practice-related. BMC Pediatr. 5, 22 (2005).
8. Perlman SE, Saiman L, Larson EL. Risk factors for late-onset health care-associated bloodstream infections in patients in neonatal intensive care units. Am. J. Infect. Control 35(3), 177-182 (2007).
9. Urrea M, Iriondo M, Thio M et al. A prospective incidence study of nosocomial infections in a neonatal care unit. Am. J. Infect. Control 31(8), 505-507 (2003). (Pubitemid 37533220)
10. van der Zwet WC, Kaiser AM, van Elburg RM et al. Nosocomial infections in a Dutch neonatal intensive care unit: Surveillance study with definitions for infection specifically adapted for neonates. J. Hosp. Infect. 61(4), 300-311 (2005).
11. Couto RC, Carvalho EA, Pedrosa TM, Pedroso ER, Neto MC, Biscione FM. A 10-year prospective surveillance of nosocomial infections in neonatal intensive care units. Am. J. Infect. Control 35(3), 183-189 (2007).
12. Haas J, Larson E, Ross B, See B, Saiman L. Epidemiology and diagnosis of hospital-acquired conjunctivitis among neonatal intensive care unit patients. Pediatr. Infect. Dis. J. 24(7), 586-589 (2005). (Pubitemid 40993610)
13. Stoll BJ, Hansen N, Fanaroff AA et al. To tap or not to tap: High likelihood of meningitis without sepsis among very low birth weight infants. Pediatrics 113(5), 1181-1186 (2004).
14. Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B. Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: A national survey. Pediatrics 109(1), 34-39 (2002).
15. Stoll BJ, Hansen N, Fanaroff AA et al. Late-onset sepsis in very low birth weight neonates: The experience of the NICHD Neonatal Research Network. Pediatrics 110(2 Pt 1), 285-291 (2002).
16. Nambiar S, Singh N. Change in epidemiology of health care-associated infections in a neonatal intensive care unit. Pediatr. Infect. Dis. J. 21(9), 839-842 (2002).
17. Ronnestad A, Abrahamsen TG, Medbo S et al. Late-onset septicemia in a Norwegian national cohort of extremely premature infants receiving very early full human milk feeding. Pediatrics 115(3), e269-e276 (2005).
18. Boyce JM, Pittet D. Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm. Rep. 51(RR-16), 1-45, quiz CE41-CE44 (2002). This guideline is an encyclopedia of hand-hygiene science, describing the microbiology of the hands, the variety of skin disinfectants available, and the standards used in the USA and Europe for licensing hand-hygiene products.
19. Pessoa-Silva CL, Dharan S, Hugonnet S et al. Dynamics of bacterial hand contamination during routine neonatal care. Infect. Control Hosp. Epidemiol. 25(3), 192-197 (2004).
20. Pittet D, Dharan S, Touveneau S, Sauvan V, Perneger TV. Bacterial contamination of the hands of hospital staff during routine patient care. Arch. Intern. Med. 159(8), 821-826 (1999).
21. Pittet D. Improving adherence to hand hygiene practice: A multidisciplinary approach. Emerging Infect. Dis. 7(2), 234-240 (2001).
22. Voss A, Widmer AF. No time for handwashing!? Handwashing versus alcoholic rub: Can we afford 100% compliance? Infect. Control Hosp. Epidemiol. 18(3), 205-208 (1997).
23. Brown SM, Lubimova AV, Khrustalyeva NM et al. Use of an alcohol-based hand rub and quality improvement interventions to improve hand hygiene in a Russian neonatal intensive care unit. Infect. Control Hosp. Epidemiol. 24(3), 172-179 (2003).
24. Harbarth S, Pittet D, Grady L et al. Interventional study to evaluate the impact of an alcohol-based hand gel in improving hand hygiene compliance. Pediatr. Infect. Dis. J. 21(6), 489-495 (2002).
25. Tenorio AR, Badri SM, Sahgal NB et al. Effectiveness of gloves in the prevention of hand carriage of vancomycin-resistant enterococcus species by health care workers after patient care. Clin. Infect. Dis. 32(5), 826-829 (2001).
26. Cohen B, Saiman L, Cimiotti J, Larson E. Factors associated with hand hygiene practices in two neonatal intensive care units. Pediatr. Infect. Dis. J. 22(6), 494-499 (2003).
27. Lam BC, Lee J, Lau YL. Hand hygiene practices in a neonatal intensive care unit: A multimodal intervention and impact on nosocomial infection. Pediatrics 114(5), e565-e571 (2004).
28. Pessoa-Silva CL, Hugonnet S, Pfister R et al. Reduction of health care associated infection risk in neonates by successful hand hygiene promotion. Pediatrics 120(2), e382-e390 (2007).
29. Pittet D, Hugonnet S, Harbarth S et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 356(9238), 1307-1312 (2000). Describes one of the first major programs to improve hand hygiene since that described by Semmelweis. The article was among the first to demonstrate the advantages of alcohol-based disinfectants in the hospital setting.
30. Won SP, Chou HC, Hsieh WS et al. Handwashing program for the prevention of nosocomial infections in a neonatal intensive care unit. Infect. Control Hosp. Epidemiol. 25(9), 742-746 (2004).
31. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol. 5(7), e177 (2007).
32. Favier CF, Vaughan EE, De Vos WM, Akkermans AD. Molecular monitoring of succession of bacterial communities in human neonates. Appl. Environ. Microbiol. 68(1), 219-226 (2002).
33. Goldmann DA, Leclair J, Macone A. Bacterial colonization of neonates admitted to an intensive care environment. J. Pediatr. 93(2), 288-293 (1978).
34. Berwick DM. The science of improvement. JAMA 299(10), 1182-1184 (2008).
35. Schulman J, Wirtschafter DD, Kurtin P. Neonatal intensive care unit collaboration to decrease hospital-acquired bloodstream infections: From comparative performance reports to improvement networks. Pediatr. Clin. North Am. 56(4), 865-892 (2009).
36. Laffel G, Blumenthal D. The case for using industrial quality management science in health care organizations. JAMA 262(20), 2869-2873 (1989).
37. Berwick DM. Developing and testing changes in delivery of care. Ann. Intern. Med. 128(8), 651-656 (1998).
38. Plsek P. Innovative thinking for the improvement of medical systems. Ann. Intern. Med. 131(6), 438-444 (1999).
39. Plsek PE. Quality improvement methods in clinical medicine. Pediatrics 103(1 Suppl. E), 203-214 (1999).
40. Horbar JD. The Vermont Oxford Network: Evidence-based quality improvement for neonatology. Pediatrics 103(1 Suppl. E), 350-359 (1999).
41. Rogowski JA, Horbar JD, Plsek PE et al. Economic implications of neonatal intensive care unit collaborative quality improvement. Pediatrics 107(1), 23-29 (2001). Demonstrated that collaborative quality improvement efforts in the neonatal intensive care unit (NICU) save money as well as decrease morbidity, although the benefits vary from participating center to participating center.
42. Horbar JD, Rogowski J, Plsek PE et al. Collaborative quality improvement for neonatal intensive care. NIC/Q Project Investigators of the Vermont Oxford Network. Pediatrics 107(1), 14-22 (2001). Demonstrated that collaborative quality improvement efforts in the NICU save money as well as decrease morbidity, although the benefits vary from participating center to participating center.
43. Kilbride HW, Wirtschafter DD, Powers RJ, Sheehan MB. Implementation of evidence-based potentially better practices to decrease nosocomial infections. Pediatrics 111(4 Pt 2), e519-e533 (2003).
44. Pronovost P, Needham D, Berenholtz S et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N. Engl. J. Med. 355(26), 2725-2732 (2006).
45. Miller MR, Griswold M, Harris JM et al. Decreasing PICU catheter-associated bloodstream infections: NACHRI's quality transformation efforts. Pediatrics DOI: 10.1542/peds.2009-1382 (2010) (Epub ahead of print).
46. Kacica MA, Horgan MJ, Ochoa L, Sandler R, Lepow ML, Venezia RA. Prevention of Gram-positive sepsis in neonates weighing less than 1500 grams. J. Pediatr. 125(2), 253-258 (1994).
47. Spafford PS, Sinkin RA, Cox C, Reubens L, Powell KR. Prevention of central venous catheter-related coagulase-negative staphylococcal sepsis in neonates. J. Pediatr. 125(2), 259-263 (1994).
48. Lee BE, Cheung PY, Robinson JL, Evanochko C, Robertson CM. Comparative study of mortality and morbidity in premature infants (birth weight,
49. Feja KN, Wu F, Roberts K et al. Risk factors for candidemia in critically ill infants: A matched case-control study. J. Pediatr. 147(2), 156-161 (2005).
50. Kicklighter SD, Springer SC, Cox T, Hulsey TC, Turner RB. Fluconazole for prophylaxis against Candidal rectal colonization in the very low birth weight infant. Pediatrics 107(2), 293-298 (2001).
51. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N. Engl. J. Med. 345(23), 1660-1666 (2001). Reports the seminal randomized clinical trial demonstrating that prophylactic fluconazole can reduce invasive candidiasis in low-birthweight infants.
52. Manzoni P, Stolfi I, Pugni L et al. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N. Engl. J. Med. 356(24), 2483-2495 (2007).
53. Bertini G, Perugi S, Dani C, Filippi L, Pratesi S, Rubaltelli FF. Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants. J. Pediatr. 147(2), 162-165 (2005).
54. Healy CM, Campbell JR, Zaccaria E, Baker CJ. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. Pediatrics 121(4), 703-710 (2008).
55. Manzoni P, Arisio R, Mostert M et al. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: A single-center, 6-year, retrospective cohort study. Pediatrics 117(1), e22-e32 (2006).
56. Manzoni P, Leonessa M, Galletto P et al. Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies. Pediatr. Infect. Dis. J. 27(8), 731-737 (2008).
57. Uko S, Soghier LM, Vega M et al. Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants. Pediatrics 117(4), 1243-1252 (2006).
58. Weitkamp JH, Ozdas A, LaFleur B, Potts AL. Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure. J. Perinatol. 28(6), 405-411 (2008).
59. Clerihew L, Austin N, McGuire W. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst. Rev. 4, CD003850 (2007).
60. Long SS, Stevenson DK. Reducing Candida infections during neonatal intensive care: Management choices, infection control, and fluconazole prophylaxis. J. Pediatr. 147(2), 135-141 (2005). Thoughtful analysis of the pros and cons of adopting fluconazole prophylaxis to prevent invasive Candida infections.
61. Healy CM, Baker CJ, Zaccaria E, Campbell JR. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. J. Pediatr. 147(2), 166-171 (2005).
62. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Grossman LB. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of
63. Horn DL, Neofytos D, Anaissie EJ et al. Epidemiology and outcomes of candidemia in 2019 patients: Data from the prospective antifungal therapy alliance registry. Clin. Infect. Dis. 48(12), 1695-1703 (2009).
64. Nguyen MH, Peacock JE Jr, Morris AJ et al. The changing face of candidemia: Emergence of non-Candida albicans species and antifungal resistance. Am. J. Med. 100(6), 617-623 (1996).
65. Price MF, LaRocco MT, Gentry LO. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob. Agents Chemother. 38(6), 1422-1424 (1994).
66. Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39(1), 1-8 (1995).
67. Hope W, Morton A, Eisen DP. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use. J. Hosp. Infect. 50(1), 56-65 (2002).
68. Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48(5), 503-535 (2009).